Letteratura scientifica selezionata sul tema "Tuberculosis"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Tuberculosis".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Tuberculosis"
Das, Anirban, Sibes Kumar Das, Abhijit Mandal e Arup Kumar Halder. "Cerebral tuberculoma as a manifestation of paradoxical reaction in patients with pulmonary and extrapulmonary tuberculosis". Journal of Neurosciences in Rural Practice 03, n. 03 (settembre 2012): 350–54. http://dx.doi.org/10.4103/0976-3147.102622.
Testo completoN., Rajeshwari, e Savitha A. "Tuberculosis: a great masquerader". International Journal of Contemporary Pediatrics 7, n. 7 (24 giugno 2020): 1651. http://dx.doi.org/10.18203/2349-3291.ijcp20202636.
Testo completoTrianes, Juwy. "EDUCATION ON THE IMPORTANCE OF BTA EXAMINATION TO DETECT TUBERCULOSIS IN IMPROVING HEALTHY LIFE IN COMMUNITY". Khidmah 4, n. 1 (7 giugno 2022): 426–32. http://dx.doi.org/10.52523/khidmah.v4i1.372.
Testo completoKaur, Harveen, Dilbag Singh, Amritpal Kaur, N. C. Kajal e Mukul Sharma. "Central nervous system Tuberculomas in a patient with disseminated multi-drug resistant tuberculosis; A case report". International Journal of Current Research in Medical Sciences 7, n. 1 (30 gennaio 2021): 1–5. http://dx.doi.org/10.22192/ijcrms.2021.07.01.001.
Testo completoZlata, Hajric Zidan, Pasic Amela e Selimovic Selma. "Silent Brain Tuberculomas with Acute Miliary Tuberculosis in 13-Year Old Girl - Case Report". International Journal of Health Sciences and Research 11, n. 6 (10 giugno 2021): 145–47. http://dx.doi.org/10.52403/ijhsr.20210621.
Testo completoTellez Bolaños, Vianey Guadalupe, Alejandra Lizbeth Salinas Atriano, Karla Daniela Salgado Guizar, Louis Fernando Robles Fernandez, Francisco Javier Pedraza Murillo e Roberto Camarena Álvarez. "Cerebral tuberculomas: manifestation of extrapulmonary tuberculosis in an immunocompromised patient. A case report". Iberoamerican Journal of Medicine 5, n. 4 (16 settembre 2023): 181–85. http://dx.doi.org/10.53986/ibjm.2023.0030.
Testo completoVidal, José E., Adrián V. Hernández, Augusto C. Penalva de Oliveira, Alexandre de Leite Souza, Geraldine Madalosso, Paula R. Marques da Silva e R. Dauar. "Cerebral tuberculomas in AIDS patients: a forgotten diagnosis?" Arquivos de Neuro-Psiquiatria 62, n. 3b (settembre 2004): 793–96. http://dx.doi.org/10.1590/s0004-282x2004000500010.
Testo completoSarwar, SM, e Masroor Rahman. "Isolated tuberculous thyroiditis". Bangladesh Journal of Otorhinolaryngology 22, n. 1 (22 gennaio 2020): 62–64. http://dx.doi.org/10.3329/bjo.v22i1.45087.
Testo completoB H, Parameshwar Keerthi, Anil Kumar Sakalecha, Varun S, Shivaprasad G. Savagave e Raveesha Raveesha. "An interesting case of disseminated tuberculoma of brain and spinal cord". JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 9, n. 2 (15 giugno 2019): 50–52. http://dx.doi.org/10.58739/jcbs/v09i2.1.
Testo completoSmirnov, G. A. "Variants of destructive pulmonary tuberculosis and the necessity of their differentiated treatment". Kazan medical journal 75, n. 6 (15 novembre 1994): 408–12. http://dx.doi.org/10.17816/kazmj100065.
Testo completoTesi sul tema "Tuberculosis"
Couvin, David. "Mise au point, développement et gestion d’une base de données mondiale des génotypes circulants de bacilles tuberculeux : Méthodes moléculaires et outils web pour cartographier, comprendre et maîtriser l’épidémie". Thesis, Antilles-Guyane, 2014. http://www.theses.fr/2014AGUY0791/document.
Testo completoTuberculosis (TB) is a contagious infectious disease caused by mycobacteria belonging to the Mycobacterium tuberculosis complex (MTBC). Despite numerous campaigns of vaccination by the BCG (Bacillus Calmette-Guérin) vaccine, and TB treatments, there was a resurgence of the disease since the 80s. This disruption is due to coinfection with HIV/AIDS, disorganization of health systems and the emergence of bacteria resistant to anti-TB drugs. In this context, a better understanding of the movements and changes of circulating clones of tubercle bacilli would detect faster and more relevant emerging epidemics. The control and monitoring of the disease are essential means to fight against the worldwide spread of tuberculosis. Thus the TB and Mycobacteria unit of the Pasteur Institute of Guadeloupe (IPG) has developed a database of genotypic profiles for the study of global epidemiology of tuberculosis.In this thesis, we discuss the Bioinformatical methods that have been used for the management and development of the 6th version (SITVIT2) of this database of genotypes to better understand the evolution and global dissemination of the tubercle bacillus. The database also includes several molecular markers such as MIRU-VNTRs (mycobacterial interspersed repetitive units- variable number of tandem repeats) and Spoligotype43 allowing a better description and identification of the families of genotypic profiles of Mycobacterium tuberculosis complex. SITVIT2 database is constantly evolving, and it currently contains epidemiological information on 111,635 clinical isolates. This database is available online at the following address: http://www.pasteur-guadeloupe.fr:8081/SITVIT2/. We also developed a database named "SITVITBovis", which is dedicated to bovine tuberculosis. This database will be accessible at: http://www.pasteur-guadeloupe.fr:8081/SITVIT_Bovis/.Alongside the development and management of databases, this work was based on several epidemiological and phylogeographic studies correlating data on drug resistance or demographic characteristics (including sex, age, HIV status, and the origin of the patient). Our research initiative is thus focused to further improve in depth phylogenetic characterization of MTBC lineages, as well as the epidemiological analysis of circulating clones to generate evidence-based geographical mapping of predominant clinical isolates of tubercle bacilli causing the bulk of the disease both at country and regional level. Further superposition of these maps with socio-political, economical and demographical available through Geographic Information Systems (GIS) allows to have a precise view of prevailing disparities at the level of country or sub-region. This thesis represents an important collaboration with several researchers teams also working in the field of molecular epidemiology of tuberculosis.The long-term goal of this work is to further optimize the database structure, and sustain enriching it (including automation and ease of data entry). Optimum performance and accessibility of data in the database would reinforce efforts to control and surveillance of TB in the world
Ferreira, Ester Nogueira Whyte Afonso. "Programa de controle da tuberculose : analise da coorte de tratamento de 2003, Campinas - SP". [s.n.], 2005. http://repositorio.unicamp.br/jspui/handle/REPOSIP/309607.
Testo completoDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-06T00:26:46Z (GMT). No. of bitstreams: 1 Ferreira_EsterNogueiraWhyteAfonso_M.pdf: 5612471 bytes, checksum: 293938ba956e9881ed4b939f7fca47cd (MD5) Previous issue date: 2005
Resumo: A distribuição geográfica da tuberculose tem forte relação com os indicadores socioeconômicos das diversas nações. Mesmo com os avanços no conhecimento e com a tecnologia disponível para seu controle, continua sendo grave problema mundial de saúde pública. Objetivo: Analisar a coorte de tratamento dos doentes inscritos no Programa de Controle da Tuberculose (PCT) na cidade de Campinas-SP, em 2003. Métodos: Foram analisados, segundo variáveis demográficas, clínicas e epidemiológicas, 494 doentes de uma coorte de 537 notificados no Sistema de Informação Nacional de Agravos de Notificação. Para determinar as diferenças entre as proporções e calcular as razões de chances (OR) foi utilizado o software Epi 1nfo versão 6. O valor de p foi considerado significativo quando inferior a 0,05. Resultados: Do total de doentes analisados 76,3% eram residentes no município de Campinas. O percentual de casos com a co-morbidade TB/Aids foi de 21,2% para os residentes em Campinas e de 24,8% para os residentes em outros municípios. O risco de adoecer por tuberculose em Campinas foi maior na área com piores níveis socioeconômicos. O sucesso de tratamento do grupo de doentes residentes em Campinas foi de 76,4% entre os que não apresentaram Aids e de apenas 48,8% naqueles com Aids. Os pacientes da forma clínica pulmonar com baciloscopia positiva apresentaram sucesso de 70%. O grupo constituído por pacientes que estavam em retratamento apresentou 2,1 vezes mais insucesso de tratamento comparado aos casos novos (OR = 2,14; IC 1,12 - 4,05). Entre aqueles pacientes com a co-morbidade TB/Aids a chance de insucessotambém foi maior (OR = 3,41; 1C 1,98 - 5,89). A proporção de tratamentos supervisionados foi de 35%. Conclusões: A efetividade do PCT de Campinas apresentou-se abaixo dos 85% proposto pela OMS em todas as estratificações estudadas e a incidência parece estar subdimensionada perante a baixa cobertura de baciloscopias de escarro (43,3%) nos sintomáticos respiratórios, sugerindo problemas na operacionalização do PCT de Campinas. Para melhorar o programa as atividades de busca de casos e as estratégias que asseguram a adesão ao tratamento, incluindo o tratamento supervisionado, devem ser aprimoradas
Abstract: The geographic distribution of tuberculosis has a strong relationship with socioeconomic indicators of different nations. Even with advances in knowledge and available technology for its control, it continues to be a serious worldwide public health problem. Objective: To analyze the treatment cohort of patients enrolled in the Tuberculosis Control Program (TCP) in the city of Campinas, SP, in 2003. Methods: In accordance with demographic, clinical and epidemiological variables, 494 patients IToma 537 cohort, who were notified by the National Disease Reporting Information System, were analyzed. In order to determine the differences among proportions and calculate the odds ratio (aR) the Epi Info version 6 software was used. A p value of less than 0.05 was considered significant. Results: Of the total patients analyzed, 76.3% were resident in the city of Campinas. The percentage of cases with TB/AIDS comorbidity for Campinas residents was 21.2% and for the residents in other cities, 24.8%. The risk for tuberculosis was higher in the areas with worse socioeconomic levels. The successful outcome for the treatment of the group of patients resident in Campinas was 76.4% among those who did not present Aids and only 48.8% for those who presented Aids. Patients with positive baciloscopy presented a success rate of 70%.The group of patients being retreated had a 2.1 times higher rate of unsuccessful treatment when compared to new cases (aR = 2.14; CI = 1.12 - 4.05). Among those patients with the TB/Aids comorbidity the chance of no unsuccessful was also higher (aR = 3.41; IC = 1.98 - 5.89). The proportion of supervised treatment was 35%. Conclusions: The effectiveness of the TCP in Campinas was below the 85% proposed by the WHO in all of the studies strata and the incidence seems to be underdimensioned in face of the low sputum bacilloscopy coverage (43.3%) of those presenting respiratory disease symptoms, which suggests problems in the TCP operation in Campinas. In order to improve the ~program, the activities of case search and supervised treatment should be enhanced.
Mestrado
Saude Coletiva
Mestre em Saude Coletiva
Al-Mouaiad, Al-Azem Assaad. "Epidemiology of tuberculosis in Manitoba, 1992-1997". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape7/PQDD_0002/MQ45018.pdf.
Testo completoMiyata, Marcelo [UNESP]. "Construção de um painel com isolados clínicos de Mycobacterium tuberculosis com genes de resistência a quimioterápicos, para o estudo de novas drogas anti-TB". Universidade Estadual Paulista (UNESP), 2010. http://hdl.handle.net/11449/103867.
Testo completoConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
De acordo com a Organização Mundial de Saúde em 2009, 9,27 milhões de novos casos de tuberculose ocorreram em 2007. Destes novos casos, 4,9% eram multidroga resistentes. Muitas pesquisas são realizadas na procura de novas drogas com atividade contra o bacilo da tuberculose, havendo então a necessidade de se entender os mecanismos de ação destes novos compostos. Este projeto objetivou propiciar ferramentas para compreender um pouco mais sobre os mecanismos de ação de novas drogas. Isolados clínicos de M. tuberculosis foram caracterizados quanto ao seu perfil de susceptibilidade aos fármacos do esquema terapêutico e foram determinadas as mutações responsáveis por estas resistências. Com os isolados caracterizados, foi construído um painel de M. tuberculosis. Pelo REMA, os isolados foram analisados quanto ao seu perfil de susceptibilidade aos fármacos (INH, RMP, STR e ETB) e avaliados quanto à presença de mutações nos genes de resistência (inhA, katG, ahpC, rpoβ, rpsL, rrs e embB) empregando a PCR-SSCP. Pelo REMA foram avaliados 80 isolados clínicos, sendo observada a resistência a INH em 74,7%, a RMP em 51,2%, a STR em 53,7% e ao ETB em 58,7%. Nos isolados resistentes, a porcentagem de mutações encontradas nos genes foi de 20,6% para inhA, 50% para katG, 6,3% para ahpC, 60% para rpoβ, 20% para rpsL e 0% para rrs e embB. Um painel com 12 isolados foi testado frente a três novos compostos, dois derivados de INH (Cu-INH1 e Cu-INH2) e um de RMP (Cu-RMP). Verificou-se que os isolados resistentes a INH foram também resistentes a Cu-INH1 e Cu-INH2. A mesma situação foi verificada em relação à RMP, com o composto Cu-RMP. Provavelmente, estes novos compostos têm os mesmos mecanismos de ação da INH e da RMP, que são os fármacos que lhes deram origem
According to World Health Organization in 2009, 9.27 million new TB cases occurred in 2007. Among these new cases, 4.9% were multidrug resistant. Many surveys are conducted in the search for new drugs with activity against the tuberculosis bacillus, therefore there is a need to understand the action mechanism of these new compounds. This project aimed to provide tools to understand about the action mechanisms of new drugs. M. tuberculosis clinical isolates were analyzed for their susceptibility profile to drugs, mutations responsible for resistance and a panel of these characterized isolates. The isolates were analyzed for susceptibility profile to drugs (INH, RIF, STR and ETB) and evaluated for presence of mutations in the resistance genes (inhA, katG, ahpC, rpoβ, rpsL, rrs and embB) applying the PCR-SSCP. REMA evaluated 85 clinical isolates and the resistance was observed in 74.7% to INH, 51.5% to RIF, 53.7% to STR and 58.7% to ETB. In the resistant isolates, percentage of mutations found in the genes was 20.6% for inhA, 50% for katG, 6.3% for ahpC, 60% for rpoβ, 20% for rpsL and 0% for rrs and embB. A panel of 12 isolates was tested against three new compounds, two INH-derivatives (Cu-INH1 and Cu-INH2) and one RMP-derivative (Cu-RMP). The isolates resistant to INH were also resistant to Cu-INH1 and Cu-INH2 compounds. The same situation was verified in relation to the RMP with the Cu-RMP compound, indicating that probably these three new compounds have the same action mechanism of INH and RMP drugs
Panunto, Alessandra Costa. "Genotipagem utilizando a sequencia de inserção IS6110 e "spoligotyping" de Mycobacterium tuberculosis isolados de pacientes infectados pelo HIV, em Moçambique, Africa". [s.n.], 2007. http://repositorio.unicamp.br/jspui/handle/REPOSIP/310668.
Testo completoTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-09T07:44:31Z (GMT). No. of bitstreams: 1 Panunto_AlessandraCosta_D.pdf: 4929023 bytes, checksum: e09c1fb4f0b9ff64c05e8133763291d7 (MD5) Previous issue date: 2007
Resumo: O M. Avium é um microrganismo oportunista e sua infecção é feeqüentemente encontrada em pacientes com aids no Brasil, apesar do largo uso da quimioterapia antiretroviral altamente efetiva. Este estudo documenta a relevância desse problema. Dentro de uni número significante de pacientes (n=39) infectados com o M. avium, os isolados puderam ser recuperados de uma variedade de espécimes clínicos. Todos os isolados (n=45) foram tipados pela técnica de RFLP usando a seqüência 1S1245. A maioria dos pacientes (n=35) eram infectados pelo HIV. Somente duas cepas não puderam ser tipadas por causa da ausência da seqüência detectável pela 1S1245. Nas 43 cepas restantes os "blots" apresentaram de 6 a 23 bandas. Uma média de 17 seqüências foram observadas para cada cepa. Para alguns pacientes, mais de um isolado pode ser recuperado. Em dois pacientes deste grupo com doença disseminada, o M. avium pode ser recuperado mais de uma vez. De cada paciente, pelo menos duas amostras com diferentes genótipos foram recuperadas de locais estéreis, indicando que eles tinham infecções policlonais. Esses achados têm sido relatados por outros autores. Em um estudo recente, SAAD et aI., 2000, demonstrou que isolados de infecções policlonais e diferentes "fmgerprints" podem apresentar diferentes suscetibilidade antimicrobiano. Quatro "clusters" de pacientes puderam ser identificados. O maior "cluster" foi composto de oito pacientes. Estes resultados indicam que um mecanismo de transmissão recente ocorreu. A fonte de contaminação desses microrganismos não pode ser determinada. Assim, a transmissão pessoa a pessoa não apresentou uma importância significativa na transmissão desse microrganismo. Nós supomos que esses pacientes adquiriram o microrganismo de fontes hospitalares como água, alimento ou mesmo do ambiente
Abstract: not informed.
Doutorado
Ciencias Basicas
Doutor em Clínica Médica
Barco, Patricia. "\"Caracterização molecular de mutações no gene pncA de isolados clínicos de Mycobacterium tuberculosis de origem brasileira\"". Universidade de São Paulo, 2004. http://www.teses.usp.br/teses/disponiveis/9/9136/tde-15082006-201342/.
Testo completoPyrazinamide (Z), a first-line antituberculous drug, is a prodrug that must be activated by bacterial pyrazinamidase (PZase) to the active form pyrazinoic acid, which kills M. tuberculosis. Many studies have shown that mutation in the gene encoding PZase (pncA) is the major mechanism of Z-resistance in M. tuberculosis. Based on this information and taking into consideration the absence of studies concerning Z-resistance in Brazilian M. tuberculosis strains, this study was aimed at characterizing pncA mutations and investigating its correlation with Z-resistance and PZase activity. The molecular characterization carried out by Spoligotyping revealed that all tested strains belong to M. tuberculosis species. The minimal inhibitory concentration (MIC) of Z was determined by three methods: microplate Alamar Blue assay (MABA), broth microdilution method (BMM) and method of proportions on Lowenstein-Jensen medium. The results showed a good association between the 3 methods, and MABA for MIC determination signalized a new and safe option to be used for Z. Most of Z-resistant strains (88%) presented pncA mutations as well as loss of PZase activity. Some exceptions were found since 12% of Z-resistant strains presented neither pncA mutations nor loss of PZase activity, what suggests the existence of another Z-resistance mechanism. Nine of 22 mutations found in pncA gene were described only in this study. During the course of this investigation were identified 5 Z-monoresistant M. tuberculosis strains.
Remualdo, Vanessa Rosália. "Amplificação do DNA de Mycobacterium tuberculosis presente em amostras de esfregaço bucal, pela técnica de reação em cadeia da polimerase (PCR)". Universidade de São Paulo, 2009. http://www.teses.usp.br/teses/disponiveis/23/23141/tde-17062009-170152/.
Testo completoMycobacterium tuberculosis is the causing agent of the tuberculosis, responsible illness for 26% of the prevention deaths in the entire world. In Brazil 85000new cases are notified annually, being esteem 50 million people contaminated by the M. tuberculosis. It is considered priority disease for the control of illnesses for the Health department. For this control, it has to be reliable methods and resources for the ready laboratorial diagnosis. Bacterioscopiv, histological analysis or culture of the microrganism from samples of sputum are techniques normally used. The limitation of these methods is low sensitivity and long-winded 8 weeks. The PCR is one technique of amplification of DNA, that if has shown promising instrument for the diagnosis of the tuberculosis. The M. tuberculosis is a microorganism that has affinity for the cells (intracellular microorganism) and can be present in the cells of the respiratory treat and the oral mucosa. Oral swab, in contrast of sputum, is easily taken, not invasive and offering lesser risks of contamination for other microorganisms. We analyze 80 samples of oral swab of patients with confirmed diagnosis of tuberculosis, of these, 78 (97,4%) had resulted positive in the PCR. We conclude that the oral swab use and the application of the PCR are an effective and trustworthy method for tuberculosis detention of the M. tuberculosis.
Nguyen, Thuy Van. "Utilisation des systèmes de surveillance pour évaluer les aspects particuliers de la tuberculose et de la résistance aux antituberculeux en France". Thesis, Paris 6, 2014. http://www.theses.fr/2014PA066283/document.
Testo completoTuberculosis (TB) remains a major cause of morbidity and mortality worldwide, partly because of drug resistance anf the HIV epidemics. Tuberculous meningitis (TBM) is the most severe form of the tuberculosis disease, and is one of the indicators used for the BCG vaccination policy. Multidrug resistant tuberculosis (MDR-TB), which poses diagnostic and therapeutic problems, has been monitored since 1992 in France. On the opposite, rifampicin mono-resistance (RMR) tuberculosis (TB) which represents a first step toward MDR-TB is rarely studied and the impact of rifampicin mono-resistance on patient’s outcome is unknown in France. Our work was focused on the epidemiology of MTB and the impact of changes in the BCG vaccination strategy. We used two systems implemented for the surveillance of TB in France: a nationwide laboratory network coordinated by the National Reference Centre (NRC) for Mycobacteria and Resistance of Mycobacteria to Anti-tuberculosis Drugs and the mandatory notification system of TB (MNS) coordinated by the National Institute for Public Health Surveillance (Institut de Veille Sanitaire, InVS). The NRC network was also used to evaluate Rifampicin mono-resistant tuberculosis in France. First, we assessed the incidence rate of culture-positive (C+) central nervous system tuberculosis (CNS TB) in France in 2007 (the year of the changing policy on BCG vaccination) and its time trend between 1990 and 2007. In 2007, CNS TB represented less than 1% of all culture-positive TB cases and its incidence was around 0.50 per million inhabitants. The 2007 sensitivity of the NRC was 79.4%. To assess the evolution of C+ CNS TB between 1990 and 2007, we used an average sensitivity derived from the 2000 sensitivity of the NRC (75.6%) and the sensitivity for the year 2007. The average sensitivity was used to correct the number of C+ CNS TB reported in four surveys (1990, 1995, 2000, 2007). There was a major decrease of 62% in the extrapolated number of C+ CNS TB in seventeen years (from 90 to 35 cases), and in the extrapolated incidence rate (from 1.6 to 0.55 cases per million inhabitants) (P < 0.001). Then, we measured the impact of two major changes in BCG vaccination policy in 2006 (disappearance of the multipuncture device for BCG) and 2007 (end of compulsory BCG vaccination) on the epidemiology of TBM in children under 6 years in France between 2000 and 2011. Overall, 10 culture-positive and 17 possible (negative-culture or unknown microbiological result) cases of TBM were identified, with an annual incidence rate varying from 0.16 to 0.66 cases / 10 million inhabitants. In Ile-de-France, where all children are considered “at risk” and therefore should all be vaccinated, and in the other regions where only at-risk children are considered for vaccination since 2007, no statistically significant differences in the annual incidences rates for each one-year age-group cohort could be observed. These results reinforce the 2007 decision to stop universal BCG vaccination. However, a close monitoring of CNS TB in the coming years will be needed to assess the long-term impact of the new vaccination policy. Finally, we built, through the NRC national network of laboratories, a retrospective cohort of RMR TB cases diagnosed between 2005 and 2010. A total of 39 cases with RMR TB were identified (0.12% of all TB culture positive cases). Among all patients, 19 (49%) had a previous history of TB treatment, and 9 (23%) were HIV-coinfected. Data about treatment and outcome were available for 30 of 39 patients and only 20 (67%) were considered as cured. Treatments received both in terms of drugs and duration were heterogeneous. These results suggest the need to improve the management of patients with RMR TB in France
Hill, Véronique. "Phylogéographie mondiale des bacilles tuberculeux : contribution des outils moléculaires et bioinformatiques et caractérisation des lignées génotypiques pour des études épidémiologiques et phylogénétiques". Thesis, Antilles-Guyane, 2012. http://www.theses.fr/2012AGUY0518/document.
Testo completoTuberculosis, very old disease, is more than ever presented on the global health scene with 9 million new cases per year. This disease, which remains a major cause of mortality is one of the most intractable public health and international issues. The various control programs, launched by the World Health Organization (WHO) to prevent and guarantee the cure of tuberculosis patients face difficulties that undermine their effectiveness. Indeed, the expansion of human virus rinimunodéficience (VIII) and its negative influence on susceptibility to tuberculosis, the rapid growth of multidrug-resistant tuberculosis, poverty and population growth, are a set of factors detrimental to application of preventive and curative measures. The difficult economic circumstances undoubtedly leading to accumulation of these factors have a break between rich and poor countries about the impact and the revolution of tuberculosis worldwide. To address the disparity of the results of tuberculosis struggles, the methodologies used in epidemiology of tuberculosis must be part of a process efficiency. Molecular indispensable to the identification and classification of strains belonging to the Mycobacterium tuberculosis complex (MTC) markers each have their own potentials that need to be identified for proper use in epidemiological and phylogenetic studies. The purpose of this thesis is to extract new knowledge of the results of genotyping data stored in databases, knowledge of the polymorphism of genomic carrier to estimate the contribution of each marker in the classification of TCM. The use of different methods of phylogenetic reconstruction and modeling data was essential. In light of the results obtained, the thesis proposes a new classification methodology for a robust recovery phylogeography of TCM in connection with the history of human migration have started in sub-Saharan Africa. Each genotyping method with cost efficiency and equity, should be measured in relation to the resources available and discounts results, it is interesting to strengthen the knowledge of markers and propose alternatives leading to the classification of mycobacteria. Thus, the results obtained in this thesis bring more coherence to the proposed characterization of clones MTC circulating worldwide solutions
Miyata, Marcelo. "Construção de um painel com isolados clínicos de Mycobacterium tuberculosis com genes de resistência a quimioterápicos, para o estudo de novas drogas anti-TB /". Araraquara : [s.n.], 2010. http://hdl.handle.net/11449/103867.
Testo completoAbstract: According to World Health Organization in 2009, 9.27 million new TB cases occurred in 2007. Among these new cases, 4.9% were multidrug resistant. Many surveys are conducted in the search for new drugs with activity against the tuberculosis bacillus, therefore there is a need to understand the action mechanism of these new compounds. This project aimed to provide tools to understand about the action mechanisms of new drugs. M. tuberculosis clinical isolates were analyzed for their susceptibility profile to drugs, mutations responsible for resistance and a panel of these characterized isolates. The isolates were analyzed for susceptibility profile to drugs (INH, RIF, STR and ETB) and evaluated for presence of mutations in the resistance genes (inhA, katG, ahpC, rpoβ, rpsL, rrs and embB) applying the PCR-SSCP. REMA evaluated 85 clinical isolates and the resistance was observed in 74.7% to INH, 51.5% to RIF, 53.7% to STR and 58.7% to ETB. In the resistant isolates, percentage of mutations found in the genes was 20.6% for inhA, 50% for katG, 6.3% for ahpC, 60% for rpoβ, 20% for rpsL and 0% for rrs and embB. A panel of 12 isolates was tested against three new compounds, two INH-derivatives (Cu-INH1 and Cu-INH2) and one RMP-derivative (Cu-RMP). The isolates resistant to INH were also resistant to Cu-INH1 and Cu-INH2 compounds. The same situation was verified in relation to the RMP with the Cu-RMP compound, indicating that probably these three new compounds have the same action mechanism of INH and RMP drugs
Orientador: Clarice Queico Fujimura Leite
Coorientador: Cleslei Fernando Zanelli
Banca: Elsa Mases Mamizuka
Banca: Daisy Nakamura Sato
Banca: Eliana Aparecida Varanda
Banca: Mario Hiroyuki Hirata
Doutor
Libri sul tema "Tuberculosis"
O, Davies P. D., Barnes Peter F. 1956- e Gordon Stephen B, a cura di. Clinical tuberculosis. 4a ed. London: Hodder Arnold, 2008.
Cerca il testo completoDavid, Schlossberg, a cura di. Tuberculosis: And non-tuberculous mycobacterial infections. 4a ed. Philadelphia: Saunders, 1999.
Cerca il testo completoed, Pálfi György, a cura di. Tuberculosis past and present: Tuberculosis múlt és jelen : tuberculose : passé et présent. Szeged: Golden Book and Tuberculosis Foundation, 1999.
Cerca il testo completoGyögy, Pálfi, a cura di. Tuberculosis: Past and present = Tuberculosis: múlt és jelen = Tuberculose: passé et présent. [S.l.]: Golden Books/TB Foundation, 1999.
Cerca il testo completoSilverstein, Alvin. Tuberculosis. Hillside, N.J: Enslow Publishers, 1994.
Cerca il testo completoSchlesinger, Larry S., e Lucy E. DesJardin. Tuberculosis. London: Taylor & Francis, 2022. http://dx.doi.org/10.1201/9780429091063.
Testo completoMigliori, Giovanni Battista, Graham Bothamley, Raquel Duarte e Adrian Rendon, a cura di. Tuberculosis. Sheffield, United Kingdom: European Respiratory Society, 2018. http://dx.doi.org/10.1183/2312508x.erm8218.
Testo completoBloom, Barry R., a cura di. Tuberculosis. Washington, DC, USA: ASM Press, 1994. http://dx.doi.org/10.1128/9781555818357.
Testo completoSchlossberg, David, a cura di. Tuberculosis. New York, NY: Springer New York, 1988. http://dx.doi.org/10.1007/978-1-4684-0305-3.
Testo completoMadkour, M. Monir, a cura di. Tuberculosis. Berlin, Heidelberg: Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-642-18937-1.
Testo completoCapitoli di libri sul tema "Tuberculosis"
Panaiotov, Stefan, Massimo Amicosante, Marc Govaerts, Patrick Butaye, Elizabeta Bachiyska, Nadia Brankova e Victoria Levterova. "Mycobacterium tuberculosis: Tuberculosis". In BSL3 and BSL4 Agents, 322–25. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2012. http://dx.doi.org/10.1002/9783527645114.ch23.
Testo completoPanaiotov, Stefan, Massimo Amicosante, Marc Govaerts, Patrick Butaye, Elizabeta Bachiyska, Nadia Brankova e Victoria Levterova. "Mycobacterium Tuberculosis: Tuberculosis". In BSL3 and BSL4 Agents, 149–71. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2012. http://dx.doi.org/10.1002/9783527645114.ch9.
Testo completoSotgiu, Giovanni, Matteo Zignol e Mario C. Raviglione. "Tuberculosis tuberculosis , Epidemiology tuberculosis epidemiology of". In Encyclopedia of Sustainability Science and Technology, 11129–48. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0851-3_852.
Testo completoLutwick, Larry I. "Introduction". In Tuberculosis, 1–4. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4899-2869-6_1.
Testo completoLandesman, Sheldon H. "Ethical and legal aspects of tuberculosis control". In Tuberculosis, 238–51. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4899-2869-6_10.
Testo completoBarber, Peter G., William M. Goldman, Annette J. Stahl Avicolli, Rosemary Smith, Neal Rairden, Octavio Maragni, Jeneane Chirico e Constance Mangone. "Antitubercular drugs". In Tuberculosis, 252–94. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4899-2869-6_11.
Testo completoGradon, Jeremy D. "Antituberculous therapy". In Tuberculosis, 295–316. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4899-2869-6_12.
Testo completoJohnson, Livette S., e Kent A. Sepkowitz. "Treatment of multi-drug-resistant tuberculosis". In Tuberculosis, 317–30. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4899-2869-6_13.
Testo completoChapnick, Edward K. "Non-tuberculous mycobacterial infections". In Tuberculosis, 331–69. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4899-2869-6_14.
Testo completoPesanti, Edward L. "A history of tuberculosis". In Tuberculosis, 5–19. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4899-2869-6_2.
Testo completoAtti di convegni sul tema "Tuberculosis"
CARVALHO, L. F., e J. M. W. PINHATA. "AVALIAÇÃO DAS CEPAS COM RESULTADOS NEGATIVOS PARA O COMPLEXO Mycobacterium tuberculosis NO TESTE GENOTYPE MTBDRplus NA ROTINA DO NÚCLEO DE TUBERCULOSE E MICOBACTERIOSES". In III Mostra Dos Trabalhos De Conclusão De Curso Da Especialização Em Vigilância Laboratorial Em Saúde Pública. Agron Science, 2022. http://dx.doi.org/10.53934/10103-2.
Testo completoDunga, Lucas Medeiros, Renner Cassio Nunes de Lucena, Matheus Araújo de Medeiros, Brendo Bezerra Benvenuto, Tiago Lameque de Sousa e. Silva, Maria Eduarda Medeiros Martins, Fabricia dos Santos Almeida et al. "Cerebral tuberculoma as a differential diagnosis for extraaxial lesions in immunocompetent patient: case report". In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.630.
Testo completoAmaral Neto, Antonio Serpa do, Eduarda Jaskulski, Eduardo Martins Leal, Matheus Marquardt, Gabriel de Deus Vieira e Joana Capano Hawerroth. "Neurotuberculosis with intracerebral tuberculoma and PCR for detectable Mycobacterium in CSF". In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.710.
Testo completoRIVABEM, ANA MARIA, VINICIUS HOFFMANN DE OLIVEIRA, GABRIELA CRISTINA LEME DE CARVALHO, SABRINA PINA FINGER e BEATRIZ ESSENFELDER BORGES. "REAÇÃO GRANULOMATOSA INDUZIDA PELA MYCOBACTERIUM TUBERCULOSIS, UMA REVISÃO INTEGRATIVA". In II Congresso Brasileiro de Imunologia On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/ii-conbrai/5018.
Testo completoGayoso, O. D., S. K. Salazar Gavino, O. A. Gayoso Liviac, K. B. Tafur, C. Casani, G. Zumaeta, E. S. Valdivia et al. "Tuberculous Otomastoiditis Associated with Miliary Tuberculosis and Panhypopituitarism". In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4026.
Testo completojeong, yunjeong, Jae Seuk Park, Hyung Woo Kim, Jinsoo Min, Yousang Ko, Jee Youn Oh, Eun Hye Lee et al. "Deaths from Tuberculosis: Differences between Tuberculosis-related and Non-tuberculosis-related Deaths". In ERS International Congress 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/13993003.congress-2023.pa2179.
Testo completoMercês, Thacyanne Marques Das, Rafaela Cardoso De Moraes Fracalossi, Stefani Thalita Vieira Alves e Alcione De Oliveira Santos. "TUBERCULOSE MILIAR EM PACIENTES COM LÚPUS ERITEMATOSO SISTÊMICO JUVENIL". In I Congresso Brasileiro de Doenças Infectocontagiosas On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/2204.
Testo completoSilva, Jallysson Santos, CAIO ARAUJO DA CUNHA, DENNIS MIGUEL LEMOS DA SILVA e STEFAN VILGES DE OLIVEIRA. "ANÁLISE EPIDEMIOLÓGICA E PROPOSTA DE INTERVENÇÃO PARA OS CASOS DE TUBERCULOSE EM UBERLÂNDIA-MG". In I Congresso Brasileiro de Estudos Epidemiológicos On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/epidemion/7130.
Testo completoGomar, Gabriella Giandotti, e Rogerio Saad Vaz. "O ACOMETIMENTO PULMONAR DA COINFECÇÃO DE COVID-19 COM TUBERCULOSE: UMA REVISÃO INTEGRATIVA DA LITERATURA". In I Congresso Brasileiro de Doenças Infectocontagiosas On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/2243.
Testo completoGniech, Ana Laísa, Nathalia Regina Gniech, Thiago Roberto Polese, Fernanda Maurer D'Agostini e Liliane Simara Fernandes. "TUBERCULOSE: PERFIL EPIDEMIOLÓGICO NO ESTADO DE SANTA CATARINA, FATORES DE RISCO E RESISTÊNCIA MICROBIANA". In I Congresso Brasileiro de Parasitologia Humana On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/682.
Testo completoRapporti di organizzazioni sul tema "Tuberculosis"
Kamma, Dr Prudhvi Srujan, e Dr Aishwarya Badugu. AN UNUSUAL PRESENTATION OF EXTRAPULMONARY TUBERCULOSIS AS FEVER WITH PANCYTOPENIA: A CASE REPORT. World Wide Journals, febbraio 2023. http://dx.doi.org/10.36106/ijar/5105754.
Testo completoWynand J. Goosen, Wynand J. Goosen. Combating tuberculosis in African rhinoceros. Experiment, luglio 2018. http://dx.doi.org/10.18258/11547.
Testo completoJayasimha, Sudhindra, e Anthony Devasia. Contemporary diagnosis of genitourinary tuberculosis. BJUI Knowledge, gennaio 2021. http://dx.doi.org/10.18591/bjuik.0555.
Testo completoMahkota, Renti, e Mathuros Tipayamongkholgul. Epidemiology of Tuberculosis and Multidrug-Resistance Tuberculosis In Indonesia: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, settembre 2023. http://dx.doi.org/10.37766/inplasy2023.9.0016.
Testo completoMiller, Joy M., e Martin A. Puckett. Annual US Air Force Tuberculosis Report, 1995. Fort Belvoir, VA: Defense Technical Information Center, maggio 1996. http://dx.doi.org/10.21236/ada309885.
Testo completoCHITATE, F., G. FOSGATE e A. BOSHOFF. Namibia’s demonstration of freedom from bovine tuberculosis. O.I.E (World Organisation for Animal Health), ottobre 2019. http://dx.doi.org/10.20506/bull.2019.nf.3014.
Testo completoBermúdez Pinzón, Lissete Andrea. Comportamiento epidemiológico de la tuberculosis, Colombia, 2019. Instituto Nacional de Salud, gennaio 2021. http://dx.doi.org/10.33610/01229907.2021v3n1a3.
Testo completoYu, Guocan, Yanqin Shen, Bo Ye e Yan Shi. Diagnostic accuracy of Mycobacterium tuberculosis cell free DNA for tuberculosis: A protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, novembre 2020. http://dx.doi.org/10.37766/inplasy2020.11.0101.
Testo completoMinogina, Tatyana, e Elena Sabadash. Phthisiology. SIB-Expertise, gennaio 2024. http://dx.doi.org/10.12731/er0773.29012024.
Testo completoBryan Pasqualucci, Bryan Pasqualucci. Rapid Detection of Tuberculosis -SCSU-New Haven iGEM. Experiment, luglio 2016. http://dx.doi.org/10.18258/7393.
Testo completo